您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Bohemine
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Bohemine
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Bohemine图片
CAS NO:189232-42-6
规格:98%
分子量:340.42
包装与价格:
包装价格(元)
5mg电议
25mg电议

产品介绍
CDK inhibitor
CAS:189232-42-6
分子式:C18H24N6O
分子量:340.42
纯度:98%
存储:Store at -20°C

Background:

IC50: 1 μM for cyclin-dependent kinase


A highly conserved array of mechanisms regulating cyclin-dependent kinases (CDK), which govern the timing of cell cycle progression and division, has developed in eukaryotes. CDK inhibitors have been shown to play an key regulatory role in cell proliferation, differentiation, senescence, as well as programmed death.


In vitro: Bohemine was applied to cultures of mouse hybridoma cells in order to evaluate its capacity of cell growth and the production of monoclonal antibody. Results showed that addition of bohemine at concentrations in the range of 1-10 μM led to a short-term arrest of growth and monoclonal antibody production. Such short-term suppression of cell functions was followed by a significant temporary increase of specific growth rate and specific production rate. In semicontinuous cultures, the steady-state viable cell density values showed a certain stimulation of cell growth in the presence of bohemine at micromolar concentrations, and growth inhibition at 10 and 30 μM [1].


In vivo: In mice, bohemine was found to be rapidly and completely metabolized and disappeared from circulation during the first 60 min following i.v. administration. Moreover, the metabolites were eliminated by the hepatobiliary tract and also by renal excretion [2].


Clinical trial: Up to now, bohemine is still in the preclinical development stage.


参考文献:
[1] Franek F,Strnad M,Havlícek L,Siglerová V,Fismolová I,Eckschlager T.  Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture. Cytotechnology.2001 Jul;36(1-3):117-23.
[2] Chmela Z,Vesel J,Lemr K,Rypka M,Hanus J,Havlícek L,Krystof V,Michnová L,Fuksová K,Lukes J.  In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route. Drug Metab Dispos.2001 Mar;29(3):326-34.